LIVE WEBINAR
February 21stĀ | 10am EST | 7pm GST
TheĀ Refractory Chronic Spontaneous Urticaria Challenge: When antihistamines are no longer an option.
Join Dr. Deepa Grandon and Dr. Fulvio Salvo as they explore breakthrough treatments for one of medicine's most challenging conditions. Whether you're a healthcare provider or someone seeking answers, this session will provide valuable insights into managing treatment-resistant urticaria.
What will we be covering?Ā
- Understanding Refractory Chronic Urticaria: Clear criteria for diagnosis and identification
- Beyond Physical Symptoms: Exploring the profound social and emotional impact on patients' daily lives
- Treatment Goals & Strategies: Establishing realistic objectives and comprehensive management approaches
- Advanced Treatment Options: Exploring alternatives when antihistamines are no longer effective
- Future of Treatment: Latest research and promising investigational agents in development
Join us onĀ February 21st,Ā 10 am EST | 7pm GST to learn all about:
The Refractory Chronic Spontaneous Urticaria Challenge:Ā When Antihistamines Are No Longer an Option
Meet your speakers:
Learn From Renowned Physicians
Dr. Deepa Grandon MD, MBA
A triple board-certified physician with 23 years of experience, Dr. Grandon is a Diplomat of the American Board of Internal Medicine, American Board of Allergy and Immunology and American Board of Lifestyle Medicine. As the founder and CEO of Transformational Life Consultancy, she focuses on preventive strategies for chronic lifestyle disease-complicated allergy/immunology conditions.
Dr.Ā Fulvio Salvo, MD, PhD
An Allergy and Clinical Immunology Consultant at Cleveland Clinic Abu Dhabi, Dr. Salvo serves as Vice-president of the Emirates Thoracic Society's Allergy and Clinical Immunology group. Specializing in drug allergy and perioperative hypersensitivity, he leads work in urticaria, angioedema, and immunodeficiencies. At the Respiratory Institute, he focuses on complex allergic conditions and innovative treatment approaches.
Join us LIVE to Address This Critical Treatment Challenge
By registering, you secure your spot for our live event.